Outcome measures used in psoriatic arthritis registries and cohorts: A systematic literature review of 27 registries or 16,183 patients-Reference-Cited by-同舟云学术

Outcome measures used in psoriatic arthritis registries and cohorts: A systematic literature review of 27 registries or 16,183 patients

Published:2021-08 Issue:4 Volume:51 Page:888-894
ISSN:0049-0172
Container-title:Seminars in Arthritis and Rheumatism
language:en
Short-container-title:Seminars in Arthritis and Rheumatism

Author:

Aouad Krystel,Moysidou Georgia,Rakotozafiarison Antsa,Fautrel Bruno,Gossec Laure

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Rheumatology

Reference46 articles.

1. Psoriatic arthritis: epidemiology, clinical features, course, and outcome;Gladman;Ann Rheum Dis,2005

2. Psoriatic Arthritis;Ritchlin;N Engl J Med,2017

3. The epidemiology of psoriatic arthritis;Ogdie;Rheum Dis Clin North Am,2015

4. International spondyloarthritis interobserver reliability exercise–the INSPIRE study: II. Assessment of peripheral joints, enthesitis, and dactylitis;Gladman;J Rheumatol,2007

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association Between Achievement of Clinical Disease Control and Improvement in Patient‐Reported Outcomes and Quality of Life in Patients With Psoriatic Arthritis in the Phase 3 SELECT‐PsA 1 and 2 Randomized Controlled Trials;ACR Open Rheumatology;2024-08

2. American College of Rheumatology and Food and Drug Administration Summit: Summary of the Meeting, May 17–18, 2022;Arthritis & Rheumatology;2024-05-28

3. Enthesitis in a European registry-based cohort of patients with psoriatic arthritis treated with tumour necrosis factor inhibitors: clinical burden, patient-reported outcomes, and treatment response;Scandinavian Journal of Rheumatology;2024-05-21

4. Unmet needs in psoriatic arthritis, a narrative review;Archives of Rheumatology;2024-05-05

5. Interleukin 17 as a central component of the pathogenesis of pain associated with immunoinflammatory process: A new “target” of pharmacotherapy;Rheumatology Science and Practice;2024-04-28